Skip to content
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboardSign in
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboard
Sign in
Transparency
  • Company
  • Our clinicians
  • Pharmacy partners
  • Where we operate
  • Accreditation
Legal
  • Terms of Service
  • Privacy Policy
  • Notice of Privacy Practices
  • Telehealth Consent
  • Auto-Renewal Terms
  • Refund & Shipping
  • Pharmacy Disclosure
  • Prescribing Policy
  • Patient Rights & Nondiscrimination
  • Texas Medical Board Complaint Notice
  • SMS Terms
  • Cookies
  • California Privacy
  • Accessibility
Support
  • support@upliftrx.co
  • Member sign in

Medical emergency? Call 911. In crisis? Call or text 988 (Suicide & Crisis Lifeline). UpLiftRX is not for emergencies.

Prescription products require an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Available to adults 18+ in states where our clinicians are licensed.

Compounded medications are prepared by state-licensed pharmacies for an individual patient and are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX provides a technology platform and is not a pharmacy or a medical provider. Medical services are provided by independent, licensed clinicians of a professional medical group (being finalized). Prescriptions are dispensed by independent, state-licensed pharmacies. Latitude Investments Management Ltd. Liability Co., a Wyoming limited liability company (filing no. 2024-001499647), 5709 Gardendale Dr, STE D, Houston, TX 77092.

Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound® and Cialis® are registered trademarks of Eli Lilly and Company. Contrave® is a registered trademark of Currax Pharmaceuticals LLC. Viagra® is a registered trademark of Viatris Specialty LLC. All trademarks are the property of their respective owners. UpLiftRX is not affiliated with or endorsed by any drug manufacturer, and generic medications are not the brand-name products.

© 2026 Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX.
  1. Home/
  2. Medications/
  3. Skin & Hair Care/
  4. Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone
Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care

Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical

Topical

Hair Foam - Minoxidil / Latanoprost / Tretinoin / Spironolactone 30 mL, 70 mg/0.5 mg/1.25 mg/5 mg/gm (7%/0.05%/0.125%/0.5%). The prescriber sets the dose.

$120/ month· visit, medication & shipping · charged only if prescribed
Specification
Just this one: start consultation

Add several treatments and check out once. $0 today; each is charged only if prescribed.

Rx only · adults 18+. Requires an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Compounded medications are prepared by a state-licensed pharmacy and are not FDA-approved.

Safety: Tretinoin makes your skin sensitive to sunlight. Important safety information

Know before you start

How Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone treatment works

How it works

Hair-loss treatment combines DHT-pathway blockers (finasteride/dutasteride) that slow the hormonal driver of pattern loss with growth stimulants (minoxidil) that extend the hair growth phase — oral or topical, matched to your pattern and tolerance.

What to expect

  • Months 1–3: shedding stabilizes; a brief 'dread shed' can occur and is normal.
  • Months 3–6: visible regrowth typically begins at the crown and hairline.
  • Months 6–12: full effect; progress photos help your clinician fine-tune.

Common side effects

  • Scalp irritation or dryness (topicals)
  • Decreased libido in a small percentage (oral finasteride)
  • Unwanted facial hair growth (topical minoxidil migration)
  • Initial temporary shedding

Safety & who it's not for

Finasteride and dutasteride must not be handled by pregnant women and are prescribed to women only in specific post-menopausal contexts. Tell your clinician about mood history and family planning.

Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone FAQ

What is Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone?

Hair Foam - Minoxidil / Latanoprost / Tretinoin / Spironolactone 30 mL, 70 mg/0.5 mg/1.25 mg/5 mg/gm (7%/0.05%/0.125%/0.5%). The prescriber sets the dose. It is compounded for you by a state-licensed 503A pharmacy and is not FDA-approved.

How much does Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone cost?

Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone starts at $120 per month through UpLiftRX. The price includes the online clinician visit, the medication, and shipping. Your card is charged only if a licensed clinician prescribes it.

How is Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone taken?

Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone is taken applied to the skin. Typical pharmacy directions read: "Apply 1 g (70 mg/500 mcg/1.25 mg/5 mg/gm) to the affected skin once daily." Your clinician sets your actual dose and schedule, and the pharmacy label on your prescription is what you follow.

Is Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone FDA-approved?

No. Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone is a compounded preparation, and compounded drugs are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Do I need a prescription for Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone?

Yes. Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone requires a prescription. Start an online visit, answer the health questionnaire, and a licensed clinician reviews it. If Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone is appropriate, the clinician prescribes it and a licensed pharmacy ships it to you.

How should I store Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone?

Store at room temperature, away from heat and moisture.

Where does Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone ship?

Pharmacies in our network can ship Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone to 42 states (not California). It is not currently available in 9 states; the online visit checks your state first. Orders typically arrive in 2 days after the pharmacy ships, and shipping is included in the price.

What does the research say about Latanoprost?

PubMed indexes 2,219 publications that mention Latanoprost, including 516 randomized trials, systematic reviews, or meta-analyses. ClinicalTrials.gov lists 278 registered studies. Study results for FDA-approved products do not transfer automatically to compounded preparations. The sources are linked on this page.

How long until results?

Hair cycles are slow: expect 3–6 months for visible change and up to 12 months for full effect. Consistency is everything.

Oral vs topical?

Topicals act locally with fewer systemic effects; orals are more convenient and slightly more potent. Your clinician will recommend based on your pattern, age, and preference.

What if I stop?

Benefits reverse over several months as the underlying pattern resumes. Most members treat it as ongoing maintenance.

Important safety information

Photosensitivity and pregnancy

Tretinoin makes your skin sensitive to sunlight. Daily broad-spectrum SPF 30+ is required while you use it. Do not use during pregnancy or while trying to conceive — discuss timing with your clinician.

Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before they are dispensed. Tell your clinician about all medications and supplements you take. Seek emergency care (call 911) for severe reactions. Report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Similar products

Similar to Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone

See all in Skin & Hair Care →
Hair Foam - Minoxidil topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Hair Foam - Minoxidil
20 mg
Hair Foam - Minoxidil + Finasteride topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Hair Foam - Minoxidil + Finasteride
3 options
Hair Foam - Minoxidil + Biotin + Finasteride topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Hair Foam - Minoxidil + Biotin + Finasteride
50 mg/50 mg /1 mg/gm
Hair Foam - Minoxidil + Finasteride + Tretinoin topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Hair Foam - Minoxidil + Finasteride + Tretinoin
2 options
Minoxidil oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Minoxidil
2.5 mg
Hair Serum - Finasteride topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Hair Serum - Finasteride
1 mg
Finasteride + Biotin oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Finasteride + Biotin
2 options
Finasteride + Minoxidil Oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Skin & Hair Care
Finasteride + Minoxidil Oral
1 mg / 2.5 mg
$120/mo
On this pageOverviewStrengths & pricesHow it's takenStorage & shippingResearch & sourcesFAQReviewsSafety
At a glance

What is Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical?

Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone is a compounded topical preparation prepared for an individual patient by a state-licensed 503A compounding pharmacy. It is not FDA-approved. Route: applied to the skin. Through UpLiftRX it costs from $120 per month, including the online visit, the medication, and shipping. You are charged only if a licensed clinician prescribes it. It can ship to 42 states (not California).

Form
Topical
Route
Applied to the skin
Active ingredients
Hair Foam - Minoxidil, Latanoprost, Tretinoin, Spironolactone
Options
1 strength and size option
Price
$120 per month, visit and shipping included
Prescription
Required. A licensed clinician decides whether it is appropriate.
FDA status
Compounded. Not FDA-approved; FDA does not review compounded drugs before they are dispensed.
Dispensed by
A state-licensed 503A compounding pharmacy
Ships to
42 states (not California)
Storage
Store at room temperature, away from heat and moisture.
Availability
In stock at one or more pharmacies

Product details from our pharmacy network's catalog, updated October 22, 2026.

Strengths & prices

Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical strengths and prices

1 option. Prices are per month and include the online visit, the medication, and shipping; you are charged only if a clinician prescribes it.
StrengthSizePriceAvailability
70 mg/0.5 mg/1.25 mg/5 mg/gm1 each cream (70 mg total)$120In stock
How it's taken

How to take Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical

Route and directions

Route: Applied to the skin

Example pharmacy label: “Apply 1 g (70 mg/500 mcg/1.25 mg/5 mg/gm) to the affected skin once daily.”

Your clinician sets your dose and schedule. Follow the label on your own prescription, not this example.

Preparation and supplies

Mixing: None. It ships ready to use.

Storage & shipping

Storing and shipping Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical

Storage

Store at room temperature, away from heat and moisture.

Keep out of reach of children. Do not use after the beyond-use date on the label.

Shipping

Ships to 42 states (not California), typically arriving in 2 days after the pharmacy ships. Shipping is included in the price.

States it ships to

Alaska, Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia, Wyoming

Clinical research & sources

Research on the ingredients in Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical

Published research and public drug references for each active ingredient, from the U.S. National Library of Medicine (PubMed, MedlinePlus, DailyMed, RxNorm, PubChem), ClinicalTrials.gov, and FDA. These studies are about the ingredients, often in FDA-approved products. None of them tested this compounded preparation, and their results do not automatically apply to it.

Hair Foam - Minoxidil

FDA status: We found no FDA-approved drug product listing hair foam - minoxidil as an active ingredient in openFDA.

ClinicalTrials.gov: 11 registered studies. See all studies

  • NCT00151515 A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss (Phase 3), completed
  • NCT03852992 Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia (Phase 2), withdrawn
  • NCT03488108 Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women (Phase 1, Phase 2), completed

Latanoprost

FDA status: FDA has approved products that contain latanoprost, including Iyuzeh, Rocklatan, Xalatan, Xelpros.

PubMed: 2,219 publications mention Latanoprost, 516 of them trials or reviews. Search PubMed

  1. Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis. Li T et al. Ophthalmology, 2016. Systematic Review, Network Meta-Analysis. PMID 26526633 · DOI
  2. MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension. Stalmans I et al. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2024. Randomized Controlled Trial. PMID 37615697 · DOI
  3. Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials. Luo N et al. Frontiers in medicine, 2022. Systematic Review. PMID 35979215 · DOI
  4. Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma. Sawada A et al. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2012. Randomized Controlled Trial. PMID 21858678 · DOI
  5. Comparative study of latanoprost (0.005%) and bimatoprost (0.03%) in primary open angle glaucoma. Kausar N et al. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2022. Randomized Controlled Trial. PMID 37609969 · DOI

ClinicalTrials.gov: 278 registered studies. See all studies

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 43611 ↗PubChem CID 5311221 ↗Wikipedia ↗

Tretinoin

FDA status: FDA has approved products that contain tretinoin, including Renova, Retin-A, Tri-Luma, Twyneo.

ClinicalTrials.gov: 406 registered studies. See all studies

  • NCT00647556 Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage (Phase 3), completed

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 10753 ↗PubChem CID 444795 ↗Wikipedia ↗

Spironolactone

FDA status: FDA has approved products that contain spironolactone, including Aldactone, Carospir.

PubMed: 7,870 publications mention Spironolactone, 843 of them trials or reviews. Search PubMed

  1. Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial. Lee CJ et al. JAMA, 2025. Clinical Trial, Phase IV. PMID 40366680 · DOI
  2. Spironolactone for heart failure with preserved ejection fraction. Pitt B et al. The New England journal of medicine, 2014. Randomized Controlled Trial. PMID 24716680 · DOI
  3. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Williams B et al. Lancet (London, England), 2015. Randomized Controlled Trial. PMID 26414968 · DOI
  4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. Pitt B et al. The New England journal of medicine, 1999. Clinical Trial, Randomized Controlled Trial. PMID 10471456

Sources checked October 22, 2026. Listing a study is not a claim that this product is safe or effective for you; a licensed clinician makes that decision.

Patient reviews

Reviews come only from patients who received Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical through UpLiftRX. Each is checked for privacy and safety before it's published; we never remove a review for being negative. Individual experiences vary, and reviews aren't medical advice.

No reviews yet. Patients who receive Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical through UpLiftRX can leave a review after delivery.

For patients who received Hair Foam - Minoxidil + Latanoprost + Tretinoin + Spironolactone Topical.
· DOI
  • Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis. Elshahat A et al. BMC cardiovascular disorders, 2024. Systematic Review, Meta-Analysis. PMID 39271992 · DOI
  • ClinicalTrials.gov: 329 registered studies. See all studies

    MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 9997 ↗PubChem CID 5833 ↗Wikipedia ↗